NASDAQ:ALRN - Aileron Therapeutics, Inc.
$0.51
 $-0.03
-6.39%
4:00PM EDT
2019-07-22
Aileron Therapeutics, Inc., incorporated on August 6, 2001, is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and metabolic diseases and inflammation. The Company is advancing its lead oncology program to deliver efficacy and safety in a spectrum of solid and hematological malignancies. Its lead product candidate, ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers. The Company is conducting an ongoing Phase I clinical trial of ALRN-6924 in adult patients with solid tumors or lymphomas expressing non-mutated or wild-type p53 that are refractory to or intolerant of standard therapy. ALRN-6924 may reactivate p53-mediated cell death by targeting both of the natural p53 suppressor proteins, Mouse double minute 2 homolog (MDM2) and MDMX. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ALRN     avg for
industry  
  avg for
sector  
42 stocks weight:  6. 60   217. 37   399. 45  
42 stocks rank:  4. 08 K 1. 27 K 716. 99  
# analyst opinions:  4. 00   13. 21   13. 71  
mean recommendation:  1. 20   2. 10   2. 04  

quick ratio:  2. 87   5. 49   1. 88  
current ratio:  3. 11   5. 87   2. 36  

target price low:  0. 50   83. 44   114. 90  
target price avg:  0. 93   106. 20   137. 90  
target price high:  0. 57   132. 30   158. 97  
1-yr high:  4. 25   111. 86   142. 57  
last close:  0. 54   86. 79   125. 44  
50-day avg:  0. 90   86. 68   122. 63  
200-day avg:  1. 55   89. 22   121. 38  
1-yr low:  0. 52   69. 78   100. 51  
volume:  1. 19 M 2. 62 M 3. 43 M
50-day avg volume:  275. 53 K 3. 20 M 4. 16 M
200-day avg volume:  208. 94 K 2. 99 M 4. 75 M

1-day return:  3. 64 % -1. 30 % -0. 99 %
this week return:  -16. 20 % 0. 45 % -0. 20 %
12-wk return:  -67. 57 % 0. 94 % 4. 84 %
52-wk return:  -87. 76 % -1. 30 % 10. 55 %

enterprise value (EV):  6. 51 M 45. 10 B 122. 38 B
market cap:  14. 47 M 38. 96 B 108. 40 B
EBITDA:  -30. 15 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -0. 22   5. 38   11. 93  
total debt:  5. 32 M 10. 90 B 17. 48 B
debt/equity:  41. 38   57. 18   120. 05  
net income (common):  -31. 17 M 2. 07 B 4. 05 B

shares outstanding:  14. 75 M 538. 09 M 1. 24 B
shares:  15. 98 M 548. 00 M 1. 22 B
shares short:  357. 24 K 10. 98 M 11. 87 M
shares short prior month:  458. 24 K 9. 32 M 12. 05 M
short ratio:  1. 25   5. 60   3. 34  
short % of float:  1. 82 % 6. 48 % 2. 64 %
total cash/share:  0. 50   10. 98   9. 19  
total cash:  13. 27 M 5. 93 B 6. 10 B
free cash flow:  -20. 82 M 2. 92 B 4. 55 B
operating cash flow:  -28. 50 M 3. 80 B 5. 78 B

book value:  0. 86   13. 35   27. 45  
price/book:  0. 63   4. 60   8. 78  
gross profits:  -18. 45 M 7. 44 B 36. 13 B
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -2. 11   2. 10   4. 23  
forward EPS:  -0. 87   3. 45   7. 10  
P/E:  -0. 26   1. 90   32. 10  
forward P/E:  -0. 62   6. 46   15. 47  
PE/G:  0. 00   0. 70   -0. 54  
growth:  -70. 00 % 265. 63 % 79. 11 %
earnings high:  -0. 19   0. 89   1. 68  
earnings avg:  -0. 22   0. 70   1. 57  
earnings low:  -0. 24   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -55. 61 % -2. 34 % 5. 28 %
return on equity:  -115. 83 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  1. 38   1. 27   0. 91  
sharpe (1yr):  -0. 93   0. 16   0. 77  

held % insiders:  77. 03 % 6. 06 % 3. 29 %
held % institutions:  43. 57 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : ALRN
.    100.823 =       100.823 :: --> INITIAL WEIGHT <--
.    - 2.112 =        98.711 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.945 =       191.995 :: P/E factor
.    x 2.209 =       424.108 :: PE/G factor
.    x 1.644 =       697.266 :: beta factor
.    x 0.974 =       679.406 :: sharpe factor
.     x 2.53 =      1719.126 :: current ratio factor
.    x 1.239 =      2129.747 :: quick ratio factor
.    x 1.342 =      2857.355 :: short ratio factor
.    x 1.003 =      2866.295 :: price-to-book factor
.    x 1.313 =      3763.082 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      7980.717 :: sector+industry 1-year gains factor
.    x 1.009 =       8055.96 :: industry 12-weeks return factor
.    x 1.308 =     10536.298 :: industry 2-weeks return factor
.    x 0.964 =     10156.517 :: "drift" penalty 1 days ago
.    x 0.972 =      9869.755 :: "drift" penalty 2 days ago
.    x 0.977 =      9644.573 :: "drift" penalty 3 days ago
.    x 0.972 =      9372.266 :: "drift" penalty 4 days ago
.    x 0.997 =      9342.756 :: "drift" penalty 5 days ago
.    / 2.154 =      4337.688 :: overall "drift" factor
.    x 0.872 =      3780.777 :: largest single-day jump factor
.     x 0.06 =       227.231 :: low price factor
.    x 0.148 =        33.735 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.757 =        25.534 :: forward EPS factor
.    x 0.912 =        23.278 :: forward P/E factor
.    x 1.185 =        27.578 :: industry recommendation factor
.    x 2.942 =        81.124 :: company recommendation factor
.    x 1.003 =        81.348 :: factor historical industry gain for week 29
.    x 0.958 =        77.911 :: target low factor
.    x 1.281 =        99.767 :: target mean factor
.    x 1.064 =       106.155 :: target high factor
.   x 10.166 =      1079.197 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         5.732 :: reduced for readability
.     + 0.87 =         6.601 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      6.601 :: FINAL WEIGHT for NASDAQ:ALRN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org